Literature DB >> 20100641

Spot scanning proton beam therapy for prostate cancer: treatment planning technique and analysis of consequences of rotational and translational alignment errors.

Jeff Meyer1, Jaques Bluett, Richard Amos, Larry Levy, Seungtaek Choi, Quynh-Nhu Nguyen, X Ron Zhu, Michael Gillin, Andrew Lee.   

Abstract

PURPOSE: Conventional proton therapy with passively scattered beams is used to treat a number of tumor sites, including prostate cancer. Spot scanning proton therapy is a treatment delivery means that improves conformal coverage of the clinical target volume (CTV). Placement of individual spots within a target is dependent on traversed tissue density. Errors in patient alignment perturb dose distributions. Moreover, there is a need for a rational planning approach that can mitigate the dosimetric effect of random alignment errors. We propose a treatment planning approach and then analyze the consequences of various simulated alignment errors on prostate treatments. METHODS AND MATERIALS: Ten control patients with localized prostate cancer underwent treatment planning for spot scanning proton therapy. After delineation of the clinical target volume, a scanning target volume (STV) was created to guide dose coverage. Errors in patient alignment in two axes (rotational and yaw) as well as translational errors in the anteroposterior direction were then simulated, and dose to the CTV and normal tissues were reanalyzed.
RESULTS: Coverage of the CTV remained high even in the setting of extreme rotational and yaw misalignments. Changes in the rectum and bladder V45 and V70 were similarly minimal, except in the case of translational errors, where, as a result of opposed lateral beam arrangements, much larger dosimetric perturbations were observed.
CONCLUSIONS: The concept of the STV as applied to spot scanning radiation therapy and as presented in this report leads to robust coverage of the CTV even in the setting of extreme patient misalignments. 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20100641     DOI: 10.1016/j.ijrobp.2009.07.1696

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  27 in total

1.  Robust optimization of intensity modulated proton therapy.

Authors:  Wei Liu; Xiaodong Zhang; Yupeng Li; Radhe Mohan
Journal:  Med Phys       Date:  2012-02       Impact factor: 4.071

2.  Influence of robust optimization in intensity-modulated proton therapy with different dose delivery techniques.

Authors:  Wei Liu; Yupeng Li; Xiaoqiang Li; Wenhua Cao; Xiaodong Zhang
Journal:  Med Phys       Date:  2012-06       Impact factor: 4.071

3.  PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.

Authors:  Wei Liu; Steven J Frank; Xiaoqiang Li; Yupeng Li; Ron X Zhu; Radhe Mohan
Journal:  Med Phys       Date:  2013-02       Impact factor: 4.071

4.  A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties.

Authors:  Peter C Park; X Ronald Zhu; Andrew K Lee; Narayan Sahoo; Adam D Melancon; Lifei Zhang; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-22       Impact factor: 7.038

5.  Intensity modulated proton therapy treatment planning using single-field optimization: the impact of monitor unit constraints on plan quality.

Authors:  X R Zhu; N Sahoo; X Zhang; D Robertson; H Li; S Choi; A K Lee; M T Gillin
Journal:  Med Phys       Date:  2010-03       Impact factor: 4.071

6.  Dosimetric benefits of robust treatment planning for intensity modulated proton therapy for base-of-skull cancers.

Authors:  Wei Liu; Radhe Mohan; Peter Park; Zhong Liu; Heng Li; Xiaoqiang Li; Yupeng Li; Richard Wu; Narayan Sahoo; Lei Dong; X Ronald Zhu; David R Grosshans
Journal:  Pract Radiat Oncol       Date:  2014-01-14

7.  Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errors.

Authors:  Thomas J Pugh; Richard A Amos; Sandra John Baptiste; Seungtaek Choi; Quyhn Nhu Nguyen; X Ronald Zhu; Matthew B Palmer; Andrew K Lee
Journal:  Med Dosim       Date:  2013-06-06       Impact factor: 1.482

8.  A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.

Authors:  Penny Fang; Rosemarie Mick; Curtiland Deville; Stefan Both; Justin E Bekelman; John P Christodouleas; Thomas J Guzzo; Zelig Tochner; Stephen M Hahn; Neha Vapiwala
Journal:  Cancer       Date:  2014-11-25       Impact factor: 6.860

9.  Use of treatment log files in spot scanning proton therapy as part of patient-specific quality assurance.

Authors:  Heng Li; Narayan Sahoo; Falk Poenisch; Kazumichi Suzuki; Yupeng Li; Xiaoqiang Li; Xiaodong Zhang; Andrew K Lee; Michael T Gillin; X Ronald Zhu
Journal:  Med Phys       Date:  2013-02       Impact factor: 4.071

10.  4D optimization of scanned ion beam tracking therapy for moving tumors.

Authors:  John Gordon Eley; Wayne David Newhauser; Robert Lüchtenborg; Christian Graeff; Christoph Bert
Journal:  Phys Med Biol       Date:  2014-06-03       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.